HLECTRON

HLectron's team consists of experienced technology entrepreneurs, scientists with expertise in nanotechnology and biomagnetism, biomedical engineers and clinical oncologists... Our medical systems, MagTherm and NanoMagTherm, are the outcome of large international, multidisciplinary business innovation research projects. The underpinning technology is based on targeted oxidative stress assault on cancer cells in combination with electromagnetic irradiation, to induce tumour cell death (apoptosis). As an upgrade of MagThem, NanoMagTherm is a system for cancer treatment with the potential to replace systemic chemotherapy, thus minimizing side effects and disruptively improving clinical outcome/quality of life and reducing economic burden. MagTherm has undergone successful human clinical trials, whilst NanoMagTherm has completed successful animal trials.